hepatic encephalopathy |
Disease ID | 922 |
---|---|
Disease | hepatic encephalopathy |
Definition | A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) |
Synonym | coma hepaticum enceph hepatic enceph hepatocerebral enceph portal systemic enceph portosystemic encephalopathies, hepatic encephalopathies, hepatocerebral encephalopathies, portal-systemic encephalopathies, portosystemic encephalopathy - hepatic encephalopathy hepatic encephalopathy portosystemic encephalopathy, hepatic encephalopathy, hepatocerebral encephalopathy, portal systemic encephalopathy, portal-systemic encephalopathy, portosystemic gaustad's syndrome he - hepatic encephalopathy hepatic coma/encephalopathy hepatic enceph hepatic encephalopathies hepatic encephalopathy (disorder) hepatic encephalopathy [disease/finding] hepatocerebral enceph hepatocerebral encephalopathies hepatocerebral encephalopathy hepatocerebral encephalopathy (disorder) hepatocerebral encephalopathy -retired- hepatocerebral syndrome portacaval encephalopathy portal systemic enceph portal systemic encephalopathy portal systemic encephalopathy (disorder) portal-systemic encephalopathies portal-systemic encephalopathy portosystemic enceph portosystemic encephalopathies portosystemic encephalopathy transient hepatargy syndrome |
DOID | |
UMLS | C0019151 |
MeSH | |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:46) C0023890 | cirrhosis | 40 C0023890 | liver cirrhosis | 27 C0023895 | liver disease | 15 C0019158 | hepatitis | 5 C0020538 | hypertension | 5 C0020541 | portal hypertension | 4 C0023890 | cirrhosis of liver | 4 C1527311 | brain edema | 3 C0011847 | diabetes | 2 C0085543 | epilepsia partialis continua | 1 C0011860 | type 2 diabetes mellitus | 1 C0856761 | budd-chiari syndrome | 1 C0024117 | chronic obstructive pulmonary disease | 1 C0019202 | hepatocerebral degeneration | 1 C1527311 | brain oedema | 1 C0023890 | cirrhosis liver | 1 C0015230 | rash | 1 C0151740 | elevated intracranial pressure | 1 C0024115 | pulmonary disease | 1 C0600260 | obstructive pulmonary disease | 1 C0037280 | infestation | 1 C0039445 | rendu-osler-weber disease | 1 C0032285 | pneumonitis | 1 C0008312 | biliary cirrhosis | 1 C0023794 | lipidosis | 1 C0175683 | citrullinemia | 1 C0162429 | malnutrition | 1 C0011860 | type 2 diabetes | 1 C0016977 | biliary disease | 1 C0024117 | chronic obstructive pulmonary disease (copd) | 1 C0023891 | alcoholic cirrhosis | 1 C0011849 | diabetes mellitus | 1 C0085293 | hepatitis e | 1 C0006112 | metabolic encephalopathy | 1 C0042721 | viral hepatitis | 1 C0008312 | primary biliary cirrhosis | 1 C0679466 | cognitive deficits | 1 C0039445 | osler-weber-rendu disease | 1 C0042345 | varices | 1 C0014544 | epilepsia | 1 C0154671 | cerebral degeneration | 1 C0151740 | intracranial hypertension | 1 C0014867 | esophageal varices | 1 C0020532 | hypersplenism | 1 C0038220 | status epilepticus | 1 C0023891 | alcoholic liver cirrhosis | 1 |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:13) 7124 | TNF | CTD_human 4842 | NOS1 | CTD_human 4129 | MAOB | CTD_human 2752 | GLUL | CTD_human 4128 | MAOA | CTD_human 5591 | PRKDC | CTD_human 2554 | GABRA1 | CTD_human 2638 | GC | CTD_human 4988 | OPRM1 | CTD_human 2566 | GABRG2 | CTD_human 4049 | LTA | CTD_human 706 | TSPO | CTD_human 2560 | GABRB1 | CTD_human |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:90) 31 | ACACA | 2.272 | DISEASES 37 | ACADVL | 2.148 | DISEASES 65057 | ACD | 1.036 | DISEASES 55331 | ACER3 | 1.602 | DISEASES 131 | ADH7 | 1.08 | DISEASES 174 | AFP | 3.048 | DISEASES 197 | AHSG | 1.155 | DISEASES 199 | AIF1 | 1.207 | DISEASES 229 | ALDOB | 1.32 | DISEASES 91056 | AP5B1 | 1.599 | DISEASES 361 | AQP4 | 2.194 | DISEASES 551 | AVP | 2.548 | DISEASES 554 | AVPR2 | 1.48 | DISEASES 85316 | BAGE5 | 1.032 | DISEASES 617 | BCS1L | 1.131 | DISEASES 627 | BDNF | 1.521 | DISEASES 26580 | BSCL2 | 1.842 | DISEASES 801 | CALM1 | 1.2 | DISEASES 885 | CCK | 1.683 | DISEASES 9332 | CD163 | 1.039 | DISEASES 959 | CD40LG | 1.964 | DISEASES 26586 | CKAP2 | 1.066 | DISEASES 22802 | CLCA4 | 1.092 | DISEASES 7122 | CLDN5 | 1.062 | DISEASES 1268 | CNR1 | 1.786 | DISEASES 1269 | CNR2 | 1.048 | DISEASES 1524 | CX3CR1 | 1.324 | DISEASES 1622 | DBI | 3.375 | DISEASES 1743 | DLST | 1.894 | DISEASES 1892 | ECHS1 | 1.352 | DISEASES 23644 | EDC4 | 2.174 | DISEASES 5169 | ENPP3 | 1.175 | DISEASES 51466 | EVL | 1.677 | DISEASES 2152 | F3 | 2.839 | DISEASES 2153 | F5 | 1.221 | DISEASES 2155 | F7 | 1.915 | DISEASES 2170 | FABP3 | 2.745 | DISEASES 122786 | FRMD6 | 1.151 | DISEASES 2535 | FZD2 | 1.015 | DISEASES 2638 | GC | 2.502 | DISEASES 2641 | GCG | 2.887 | DISEASES 151306 | GPBAR1 | 1.881 | DISEASES 2902 | GRIN1 | 1.559 | DISEASES 2903 | GRIN2A | 2.084 | DISEASES 2994 | GYPB | 3.026 | DISEASES 3030 | HADHA | 4.22 | DISEASES 3032 | HADHB | 2.023 | DISEASES 3055 | HCK | 1.43 | DISEASES 3363 | HTR7 | 2.967 | DISEASES 3586 | IL10 | 1.646 | DISEASES 133396 | IL31RA | 2.243 | DISEASES 81618 | ITM2C | 1.527 | DISEASES 3766 | KCNJ10 | 2.011 | DISEASES 8284 | KDM5D | 1.145 | DISEASES 81562 | LMAN2L | 1.604 | DISEASES 10046 | MAMLD1 | 1.128 | DISEASES 4128 | MAOA | 2.74 | DISEASES 4129 | MAOB | 1.732 | DISEASES 4133 | MAP2 | 1.886 | DISEASES 7867 | MAPKAPK3 | 1.505 | DISEASES 4137 | MAPT | 1.907 | DISEASES 4520 | MTF1 | 1.729 | DISEASES 654364 | NME1-NME2 | 1.284 | DISEASES 4842 | NOS1 | 3.012 | DISEASES 27035 | NOX1 | 1.029 | DISEASES 124056 | NOXO1 | 1.71 | DISEASES 9971 | NR1H4 | 1.104 | DISEASES 23022 | PALLD | 1.015 | DISEASES 5208 | PFKFB2 | 1.56 | DISEASES 5209 | PFKFB3 | 1.756 | DISEASES 3276 | PRMT1 | 1.636 | DISEASES 9050 | PSTPIP2 | 1.798 | DISEASES 5928 | RBBP4 | 1.066 | DISEASES 57127 | RHBG | 2.992 | DISEASES 6016 | RIT1 | 1.365 | DISEASES 123228 | SENP8 | 1.117 | DISEASES 462 | SERPINC1 | 1.64 | DISEASES 57468 | SLC12A5 | 1.688 | DISEASES 10165 | SLC25A13 | 4.184 | DISEASES 81539 | SLC38A1 | 1.373 | DISEASES 6540 | SLC6A13 | 1.934 | DISEASES 6533 | SLC6A6 | 2.503 | DISEASES 6654 | SOS1 | 2.571 | DISEASES 6345 | SRL | 1.479 | DISEASES 7018 | TF | 1.723 | DISEASES 7124 | TNF | 2.79 | DISEASES 79626 | TNFAIP8L2 | 1.395 | DISEASES 7133 | TNFRSF1B | 1.167 | DISEASES 706 | TSPO | 4.644 | DISEASES 7432 | VIP | 1.635 | DISEASES |
Locus | (Waiting for update.) |
Disease ID | 922 |
---|---|
Disease | hepatic encephalopathy |
Manually Symptom | UMLS | Name(Total Manually Symptoms:41) C2364118 | weakness C2364072 | depression C2364050 | hypothermia C1962971 | myocarditis C1527311 | brain edema C1522136 | hypernatremia C0851578 | sleep disturbances C0850666 | helicobacter pylori infection C0752303 | urological manifestations C0679466 | cognitive deficits C0525041 | cognitive manifestations C0476237 | metabolic symptoms C0262405 | cerebral dysfunction C0235950 | zinc deficiency C0235031 | neurological symptoms C0234428 | impaired consciousness C0234428 | disturbance of consciousness C0234378 | postural tremor C0233401 | psychiatric symptoms C0232766 | asterixis C0220983 | metabolic alkalosis C0206307 | spongy degeneration of white matter C0155773 | portal vein thrombosis C0155320 | cortical blindness C0151740 | raised intracranial pressure C0151740 | intracranial hypertension C0086439 | hypokinesia C0038220 | status epilepticus C0036939 | induced psychotic disorder C0036572 | seizures C0033975 | psychosis C0029166 | oral manifestations C0027765 | neurologic disorders C0025517 | metabolic disorders C0023890 | liver cirrhosis C0020625 | hyponatremia C0020514 | hyperprolactinemia C0018520 | breath odor C0013604 | oedema C0009951 | convulsions C0004623 | bacterial infections |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:11) C0023890 | liver cirrhosis | 26 C1527311 | brain edema | 3 C0036572 | seizures | 2 C0020625 | hyponatremia | 2 C0679466 | cognitive deficits | 1 C0038220 | status epilepticus | 1 C0232766 | asterixis | 1 C0013604 | oedema | 1 C0850666 | helicobacter pylori infection | 1 C0151740 | intracranial hypertension | 1 C0009951 | convulsions | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:5) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs211037 | 24482035 | 2566 | GABRG2 | umls:C0019151 | BeFree | Multivariate analysis indicated that hypoalbuminemia (<3 g/dL), long-acting (t 1/2 > 12-h), high-dosage (>1.5 defined daily dose equivalents) and long-duration (>2-months) BZD use, carrier of variant genotypes (AG + GG) of GABRA 1 (rs2290732) and having the wild genotype (TT) of GABRG 2 (rs211037) were significant predictors of the development of BZD-associated HE in cirrhotic patients. | 0.200271442 | 2013 | GABRG2 | 5 | 162101274 | C | T |
rs211037 | 24482035 | 2554 | GABRA1 | umls:C0019151 | BeFree | Multivariate analysis indicated that hypoalbuminemia (<3 g/dL), long-acting (t 1/2 > 12-h), high-dosage (>1.5 defined daily dose equivalents) and long-duration (>2-months) BZD use, carrier of variant genotypes (AG + GG) of GABRA 1 (rs2290732) and having the wild genotype (TT) of GABRG 2 (rs211037) were significant predictors of the development of BZD-associated HE in cirrhotic patients. | 0.200271442 | 2013 | GABRG2 | 5 | 162101274 | C | T |
rs2290732 | 24482035 | 2566 | GABRG2 | umls:C0019151 | BeFree | Multivariate analysis indicated that hypoalbuminemia (<3 g/dL), long-acting (t 1/2 > 12-h), high-dosage (>1.5 defined daily dose equivalents) and long-duration (>2-months) BZD use, carrier of variant genotypes (AG + GG) of GABRA 1 (rs2290732) and having the wild genotype (TT) of GABRG 2 (rs211037) were significant predictors of the development of BZD-associated HE in cirrhotic patients. | 0.200271442 | 2013 | GABRA1 | 5 | 161897892 | A | G |
rs2290732 | 24482035 | 2554 | GABRA1 | umls:C0019151 | BeFree | Multivariate analysis indicated that hypoalbuminemia (<3 g/dL), long-acting (t 1/2 > 12-h), high-dosage (>1.5 defined daily dose equivalents) and long-duration (>2-months) BZD use, carrier of variant genotypes (AG + GG) of GABRA 1 (rs2290732) and having the wild genotype (TT) of GABRG 2 (rs211037) were significant predictors of the development of BZD-associated HE in cirrhotic patients. | 0.200271442 | 2013 | GABRA1 | 5 | 161897892 | A | G |
rs267606959 | 20142534 | 5428 | POLG | umls:C0019151 | BeFree | To describe a novel POLG missense mutation (c.3218C>T; p.P1073L) that, in association with 2 previously described mutations, caused an Alpers-like hepatocerebral syndrome in 4 children. | 0.000271442 | 2010 | POLG | 15 | 89318986 | G | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Disease ID | 922 |
---|---|
Disease | hepatic encephalopathy |
Case | (Waiting for update.) |